Rebecca Gardner

Title: Innovations by Rebecca Gardner

Introduction

Rebecca Gardner is an accomplished inventor based in Seattle, WA. She has made significant contributions to the field of immunotherapy and cell therapy, holding a total of 3 patents. Her work focuses on developing early intervention methods to prevent or ameliorate toxicity associated with various therapies.

Latest Patents

One of her latest patents involves methods for preventing or ameliorating toxicity caused by therapies such as immunotherapy or cell therapy. The patent outlines the pre-emptive or early administration of toxicity-targeting agents. In certain embodiments, the therapy involves cell therapy where the cells express recombinant receptors, including chimeric antigen receptors (CARs) or transgenic receptors like T cell receptors (TCRs). The methods emphasize the timing of administration, which offers advantages such as reduced toxicity while maintaining the persistence and efficacy of the administered cells.

Career Highlights

Rebecca Gardner is currently affiliated with Seattle Children's Hospital, where she continues her research and innovation in the field of therapeutic interventions. Her work has garnered attention for its potential to improve patient outcomes in therapies that traditionally carry high toxicity risks.

Collaborations

Rebecca collaborates with Michael C. Jensen, a notable figure in the field, to further advance their research initiatives.

Conclusion

Rebecca Gardner's innovative approaches to mitigating therapy-related toxicity highlight her significant role in advancing medical science. Her contributions are paving the way for safer and more effective treatment options for patients.